Gladstone welcomes inquiries from journalists. Our media relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
Contact
For media inquiries or interview requests, email media-relations@gladstone.org
Kelly Quigley
Director, Science Communications & Media Relations
Direct line: 858-997-9462
Email
Julie Langelier
Associate Director, Communications
Direct line: 415-734-5000
Email
News Releases
61 - 75 of 202 Results
A Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors
A Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors
Scientists develop a new approach that produces enough cells for therapeutic applications
News Release Research (Publication) Genomic Immunology Esensten Lab Eyquem Lab Marson Lab CRISPR/Gene EditingGiving Immunotherapy Cells Resilience to Pass the “Stress Test”
Giving Immunotherapy Cells Resilience to Pass the “Stress Test”
A Gene Not Previously Known to Regulate Immunity Could Turn Tired T-Cells Around
News Release Research (Publication) Cancer Genomic Immunology Carnevale Lab Marson LabScientists Engineer DNA “Receipt Book” to Store Cells’ History
Scientists Engineer DNA “Receipt Book” to Store Cells’ History
Gladstone scientists engineer living biosensors to track the genetic activity of cells
News Release Research (Publication) Data Science and Biotechnology Shipman LabWhat Makes Omicron More Infectious Than Other COVID-19 Variants
What Makes Omicron More Infectious Than Other COVID-19 Variants
Researchers used virus-like particles to identify which mutations of the Omicron SARS-CoV-2 virus make it more effective at infecting cells and escaping antibodies
News Release Research (Publication) COVID-19 Virology Doudna Lab Ott LabBETting On COVID-19: Study Probes Role of BET Proteins in Coronavirus Infection
BETting On COVID-19: Study Probes Role of BET Proteins in Coronavirus Infection
Gladstone researchers find new evidence against using BET inhibitors to treat COVID-19
News Release Research (Publication) COVID-19 Virology Ott LabScientists Map Networks of Disease-Associated Immune Genes
Scientists Map Networks of Disease-Associated Immune Genes
The new immune networks have implications for developing immunotherapies and understanding autoimmune diseases
News Release Research (Publication) Autoimmune Diseases Genomic Immunology Marson LabPathway Deep in the Brain Makes It Resilient after Injury
Pathway Deep in the Brain Makes It Resilient after Injury
Study suggests that targeting a protein in the thalamus could block the long-term damage that follows brain injuries
News Release Research (Publication) Traumatic Brain Injury Neurological Disease Paz LabFinding HIV’s Sweet Spot
Finding HIV’s Sweet Spot
Gladstone scientists uncover novel aspects of HIV infection by monitoring sugars at the surface of individual immune cells
News Release Research (Publication) HIV/AIDS Virology Roan LabThe 2022 Ogawa-Yamanaka Stem Cell Prize Awarded to Juan Carlos Izpisua Belmonte
The 2022 Ogawa-Yamanaka Stem Cell Prize Awarded to Juan Carlos Izpisua Belmonte
Izpisua Belmonte is recognized for his innovative work in programming cellular rejuvenation
Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCsScientists Prevent “Exhaustion” in Cancer-Fighting T Cells
Scientists Prevent “Exhaustion” in Cancer-Fighting T Cells
The new study paves the way toward more effective cancer immunotherapies
News Release Cancer Genomic Immunology Marson Lab“Natural Immunity” from Omicron is Weak and Limited, Study Finds
“Natural Immunity” from Omicron is Weak and Limited, Study Finds
Without vaccination, infection with Omicron fails to confer robust immunity against other COVID-19 variants
News Release Research (Publication) COVID-19 Virology Doudna Lab Ott Lab Roan LabThrowing Drug Resistance for a Loop
Throwing Drug Resistance for a Loop
New class of resistance-proof drugs could one day transform treatments for viral diseases
News Release Research (Publication) Center for Cell Circuitry Virology Weinberger Lab ChaturvediZeroing in on a New Treatment for Autism and Epilepsy
Zeroing in on a New Treatment for Autism and Epilepsy
Gladstone scientists show that reducing levels of the protein tau soon after birth can prevent these conditions in an experimental model
News Release Research (Publication) Epilepsy Neurological Disease Mucke LabA New Toolkit To Engineer Safe and Efficient Therapeutic Cells
A New Toolkit To Engineer Safe and Efficient Therapeutic Cells
Scientists from Gladstone and UC San Francisco systematically tested ways to improve the efficacy of therapeutic cells targeting cancer
News Release Research (Publication) Cancer Genomic ImmunologyMini-Livers on a Chip
Mini-Livers on a Chip
A new platform designed by Gladstone scientists for studying how the immune system responds to hepatitis C virus could speed the hunt for a vaccine
News Release Research (Publication) Hepatitis C Virology McDevitt Lab Ott Lab Organoids
